Latest Fragrance News

International Flavors & Fragrances raised the lower end of its 2026 sales and adjusted EBITDA guidance after broad-based third-quarter growth. The stronger operating result sits alongside a US$134 million pre-tax continuing-operations loss and a costly Food Ingredients separation still awaiting completion.

Estée Lauder delivered a sharp rebound in fiscal 2027’s first quarter, with sales, margins and earnings all improving materially. The beauty group has lifted its full-year outlook, although quarterly free cash flow remained negative and the plan still depends on sustained momentum in China, travel retail and fragrance.

Sigma Healthcare has entered FY27 with double-digit Chemist Warehouse sales growth, stronger earnings and a merger integration program targeting $100 million in annual synergies by FY29. The next test is whether store expansion and technology consolidation can convert momentum into durable cash returns.

Dusk Group has carried its FY26 momentum into the new financial year, with like-for-like sales up 7.2% in the first 15 weeks despite operating six fewer stores. The home-fragrance retailer is now preparing a tightly controlled South African launch while an unresolved ACCC court case remains a material complication.

Dusk Group delivered record FY26 sales and underlying EBIT growth, driven by product rejuvenation and online momentum, while preparing for international expansion amid ACCC proceedings.

Wide Open Agriculture has appointed Craig Swan as its new CEO, signaling a strategic push to commercialise its lupin protein technology and expand its footprint in Asia.

Dusk Group Limited has reported a solid 5.2% increase in net profit for the half year ended December 2025, alongside a 5.1% rise in revenue. The company also announced a fully franked interim dividend doubling the prior payout, signalling confidence in its retail operations.

Dusk Group Limited has addressed an ASX compliance query regarding the delayed disclosure of a director’s interest change, attributing the lapse to an administrative oversight while reaffirming its commitment to regulatory compliance.

dusk Group Limited reports robust FY25 financial results with strong sales and earnings growth, while unveiling ambitious FY26 plans focused on store innovation and brand rejuvenation.

dusk Group Limited reported solid FY25 results with sales up 8.7% and EBIT rising 22.9%, driven by strong online growth and disciplined cost control. The company signals cautious optimism for FY26 amid product relaunches and store format trials.

dusk Group Limited reports a solid FY25 trading update with increased sales and EBIT, while navigating a slight dip in gross profit margin as it advances its product-led turnaround strategy.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.